Among the 95 individuals with T2D (15.2%) who received insulin therapy beyond the first 6 months postdiagnosis, 30 (4.3% of the 626 individuals with T2D) did not have diabetes autoantibody titers measured. The gene discussed is INS; the disease is type 2 diabetes mellitus.